Is Erdafitinib available in China?

Erdafitinib(Erdafitinib)on20194 pan>Month12Nikkei USFDA approved the listing, but it has not yet been launched in China. Erdafitinib is available in both original and generic versions. Currently, the original version is available in Hong Kong. The retail price in pharmacies is about 4mg 14 tablets 22,500 yuan. Generic drugs are produced in Laos and Bangladesh, Laos ASEAN Pharmaceuticals and Bangladesh Yaopin International Pharmaceuticals, and they are all on the market and have government approval. The retail price of Bangladesh Yaopin International Pharmaceutical is 4mg*60tablets2 more than a thousand, 5mg*30tablets1 more than a thousand. The retail price of pharmaceuticals in Laos and ASEAN is 4mg*28tablets2 more than a thousand, 5mg*28tablets3 more than a thousand.

Common side effects of erdafitinibIncluding laboratory abnormalities (≥20%)The most common adverse reactions include increased phosphate, stomatitis, fatigue, increased creatinine, diarrhea, dry mouth, nail abnormalities, increased alanine aminotransferase, increased alkaline phosphatase, decreased sodium, and decreased appetite , decreased albumin, dysgeusia, decreased hemoglobin, dry skin, increased aspartate aminotransferase, decreased magnesium, dry eyes, alopecia, palmar plantar dysesthesia syndrome, constipation, decreased phosphate, abdominal pain, increased calcium, nausea and musculoskeletal pain.

Erdafitinib is a once-daily oral fibroblast growth factor receptor (FGFR) kinase inhibitor that binds to and inhibits FGFR1 based on in vitro data. , FGFR2, FGFR3 and FGFR4 enzymatic activities. ErdafitinibAlso bindsRET, CSF1R, PDGFRA, PDGFRB, FLT4, KITandVEGFR2. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.